Improving management of ARDS: uniting acute management and long-term recovery.
ARDS
Chronic disability
Long-term outcome
Post-intensive care syndrome
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
23 Feb 2024
23 Feb 2024
Historique:
received:
29
10
2023
accepted:
12
01
2024
medline:
24
2
2024
pubmed:
24
2
2024
entrez:
23
2
2024
Statut:
epublish
Résumé
Acute Respiratory Distress Syndrome (ARDS) is an important global health issue with high in-hospital mortality. Importantly, the impact of ARDS extends beyond the acute phase, with increased mortality and disability for months to years after hospitalization. These findings underscore the importance of extended follow-up to assess and address the Post-Intensive Care Syndrome (PICS), characterized by persistent impairments in physical, cognitive, and/or mental health status that impair quality of life over the long-term. Persistent muscle weakness is a common physical problem for ARDS survivors, affecting mobility and activities of daily living. Critical illness and related interventions, including prolonged bed rest and overuse of sedatives and neuromuscular blocking agents during mechanical ventilation, are important risk factors for ICU-acquired weakness. Deep sedation also increases the risk of delirium in the ICU, and long-term cognitive impairment. Corticosteroids also may be used during management of ARDS, particularly in the setting of COVID-19. Corticosteroids can be associated with myopathy and muscle weakness, as well as prolonged delirium that increases the risk of long-term cognitive impairment. The optimal duration and dosage of corticosteroids remain uncertain, and there's limited long-term data on their effects on muscle weakness and cognition in ARDS survivors. In addition to physical and cognitive issues, mental health challenges, such as depression, anxiety, and post-traumatic stress disorder, are common in ARDS survivors. Strategies to address these complications emphasize the need for consistent implementation of the evidence-based ABCDEF bundle, which includes daily management of analgesia in concert with early cessation of sedatives, avoidance of benzodiazepines, daily delirium monitoring and management, early mobilization, and incorporation of family at the bedside. In conclusion, ARDS is a complex global health challenge with consequences extending beyond the acute phase. Understanding the links between critical care management and long-term consequences is vital for developing effective therapeutic strategies and improving the quality of life for ARDS survivors.
Identifiants
pubmed: 38395902
doi: 10.1186/s13054-024-04810-9
pii: 10.1186/s13054-024-04810-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
58Informations de copyright
© 2024. The Author(s).
Références
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788.
doi: 10.1001/jama.2016.0291
pubmed: 26903337
Laffey JG, Madotto F, Bellani G, Pham T, Fan E, Brochard L, et al. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017;5:627–38.
doi: 10.1016/S2213-2600(17)30213-8
pubmed: 28624388
Summers C. Addressing the inequity of acute respiratory distress syndrome. Lancet Respir Med. 2023;11:119–21.
doi: 10.1016/S2213-2600(22)00352-6
pubmed: 36070794
Prescott HC, Sjoding MW, Langa KM, Iwashyna TJ, McAuley DF. Late mortality after acute hypoxic respiratory failure. Thorax. 2017. https://doi.org/10.1136/thoraxjnl-2017-210109 .
doi: 10.1136/thoraxjnl-2017-210109
pubmed: 28780503
Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40:502–9.
doi: 10.1097/CCM.0b013e318232da75
pubmed: 21946660
Parry SM, Huang M, Needham DM. Evaluating physical functioning in critical care: considerations for clinical practice and research. Crit Care. 2017;21:249.
doi: 10.1186/s13054-017-1827-6
pubmed: 28978333
pmcid: 5628423
De Jonghe B, Sharshar T, Lefaucheur J-P, Authier F-J, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859–67.
doi: 10.1001/jama.288.22.2859
pubmed: 12472328
Latronico N, Herridge M, Hopkins RO, Angus D, Hart N, Hermans G, et al. The ICM research agenda on intensive care unit-acquired weakness. Intensive Care Med. 2017;43:1270–81.
doi: 10.1007/s00134-017-4757-5
pubmed: 28289812
Latronico N, Rasulo F, Eikermann M, Piva S. Critical illness weakness, polyneuropathy and myopathy: diagnosis, treatment, and long-term outcomes. Critical Care. 2023 Nov 30;27(1):469. https://doi.org/10.1186/s13054-023-04676-3
Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med. 2014;42:849–59.
doi: 10.1097/CCM.0000000000000040
pubmed: 24247473
pmcid: 3959239
Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–304.
doi: 10.1056/NEJMoa1011802
pubmed: 21470008
Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, et al. Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. 2020;46:1184–93.
doi: 10.1007/s00134-020-05927-5
pubmed: 31970446
Wieske L, Dettling-Ihnenfeldt DS, Verhamme C, Nollet F, van Schaik IN, Schultz MJ, et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19:196.
doi: 10.1186/s13054-015-0937-2
pubmed: 25928709
pmcid: 4427976
Wongtangman K, Grabitz SD, Hammer M, Wachtendorf LJ, Xu X, Schaefer MS, et al. Optimal sedation in patients who receive neuromuscular blocking agent infusions for treatment of acute respiratory distress syndrome—a retrospective cohort study from a New England health care network. Crit Care Med. 2021;49:1137–48.
doi: 10.1097/CCM.0000000000004951
pubmed: 33710031
Stephens RJ, Dettmer MR, Roberts BW, Ablordeppey E, Fowler SA, Kollef MH, et al. Practice patterns and outcomes associated with early sedation depth in mechanically ventilated patients: a systematic review and meta-analysis. Crit Care Med. 2018;46:471–9.
doi: 10.1097/CCM.0000000000002885
pubmed: 29227367
pmcid: 5825247
Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023;49:727–59.
doi: 10.1007/s00134-023-07050-7
pubmed: 37326646
pmcid: 10354163
Bellaver P, Schaeffer AF, Leitao CB, Rech TH, Nedel WL. Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): a systematic review with meta-analysis and trial sequential analysis. Anaesth Crit Care Pain Med. 2023;42:101202.
doi: 10.1016/j.accpm.2023.101202
pubmed: 36804373
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704.
doi: 10.1056/NEJMoa2021436
pubmed: 32678530
Lin P, Zhao Y, Li X, Jiang F, Liang Z. Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis. Crit Care. 2021;25:122.
doi: 10.1186/s13054-021-03546-0
pubmed: 33771216
pmcid: 7995395
Chaudhuri D, Sasaki K, Karkar A, Sharif S, Lewis K, Mammen MJ, et al. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med. 2021;47:521–37.
doi: 10.1007/s00134-021-06394-2
pubmed: 33876268
pmcid: 8054852
Needham DM, Wozniak AW, Hough CL, Morris PE, Dinglas VD, Jackson JC, et al. Risk factors for physical impairment after acute lung injury in a national, multicenter study. Am J Respir Crit Care Med. 2014;189:1214–24.
doi: 10.1164/rccm.201401-0158OC
pubmed: 24716641
pmcid: 4061900
Hraiech S, Yoshida T, Annane D, Duggal A, Fanelli V, Gacouin A, et al. Myorelaxants in ARDS patients. Intensive Care Med. 2020;46:2357–72.
doi: 10.1007/s00134-020-06297-8
pubmed: 33159530
pmcid: 7648542
Schreiber MP, Colantuoni E, Bienvenu OJ, Neufeld KJ, Chen K-F, Shanholtz C, et al. Corticosteroids and transition to delirium in patients with acute lung injury. Crit Care Med. 2014;42:1480–6.
doi: 10.1097/CCM.0000000000000247
pubmed: 24589640
pmcid: 4028387
Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369:1306–16.
doi: 10.1056/NEJMoa1301372
pubmed: 24088092
pmcid: 3922401
Duprey MS, Dijkstra-Kersten SMA, Zaal IJ, Briesacher BA, Saczynski JS, Griffith JL, et al. Opioid use increases the risk of delirium in critically ill adults independently of pain. Am J Respir Crit Care Med. 2021;204:566–72.
doi: 10.1164/rccm.202010-3794OC
pubmed: 33835902
pmcid: 8491270
Wolfe KS, Patel BK, MacKenzie EL, Giovanni SP, Pohlman AS, Churpek MM, et al. Impact of vasoactive medications on ICU-acquired weakness in mechanically ventilated patients. Chest. 2018;154:781–7.
doi: 10.1016/j.chest.2018.07.016
pubmed: 30217640
pmcid: 6689081
Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46:637–53.
doi: 10.1007/s00134-020-05944-4
pubmed: 32076765
pmcid: 7224132
Ali Abdelhamid Y, Kar P, Finnis ME, Phillips LK, Plummer MP, Shaw JE, et al. Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes: a systematic review and meta-analysis. Crit Care. 2016. https://doi.org/10.1186/s13054-016-1471-6 .
doi: 10.1186/s13054-016-1471-6
pubmed: 27677709
pmcid: 5039881
Gunst J, Debaveye Y, Güiza F, Dubois J, De Bruyn A, Dauwe D, et al. Tight blood-glucose control without early parenteral nutrition in the ICU. N Engl J Med. 2023;389:1180–90.
doi: 10.1056/NEJMoa2304855
pubmed: 37754283
Jackson JC, Pandharipande PP, Girard TD, Brummel NE, Thompson JL, Hughes CG, et al. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med. 2014;2:369–79.
doi: 10.1016/S2213-2600(14)70051-7
pubmed: 24815803
pmcid: 4107313
Bienvenu OJ, Friedman LA, Colantuoni E, Dinglas VD, Sepulveda KA, Mendez-Tellez P, et al. Psychiatric symptoms after acute respiratory distress syndrome: a 5-year longitudinal study. Intensive Care Med. 2018;44:38–47.
doi: 10.1007/s00134-017-5009-4
pubmed: 29279973
Bienvenu OJ, Colantuoni E, Mendez-Tellez PA, Dinglas VD, Shanholtz C, Husain N, et al. Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study. Am J Respir Crit Care Med. 2012;185:517–24.
doi: 10.1164/rccm.201103-0503OC
pubmed: 22161158
pmcid: 3297105
Hatch R, Young D, Barber V, Griffiths J, Harrison DA, Watkinson P. Anxiety, depression and post traumatic stress disorder after critical illness: a UK-wide prospective cohort study. Crit Care. 2018;22:310.
doi: 10.1186/s13054-018-2223-6
pubmed: 30466485
pmcid: 6251214
Fernando SM, Qureshi D, Sood MM, Pugliese M, Talarico R, Myran DT, et al. Suicide and self-harm in adult survivors of critical illness: population based cohort study. BMJ. 2021;373:n973.
doi: 10.1136/bmj.n973
pubmed: 33952509
pmcid: 8097311
Kotfis K, Ely EW, Shehabi Y. Intensive care unit delirium—a decade of learning. Lancet Respir Med. 2023;11:584–6.
doi: 10.1016/S2213-2600(23)00222-9
pubmed: 37414511
Wang L, Hua Y, Wang L, Zou X, Zhang Y, Ou X. The effects of early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis. Front Med (Lausanne). 2023;10:1202754.
doi: 10.3389/fmed.2023.1202754
pubmed: 37448799
Patel BK, Wolfe KS, Patel SB, Dugan KC, Esbrook CL, Pawlik AJ, et al. Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial. Lancet Respir Med. 2023. https://doi.org/10.1016/S2213-2600(22)00489-1 .
doi: 10.1016/S2213-2600(22)00489-1
pubmed: 38142696
pmcid: 10156429
Eikermann M, Needham DM, Devlin JW. Multimodal, patient-centred symptom control: a strategy to replace sedation in the ICU. Lancet Respir Med. 2023. https://doi.org/10.1016/S2213-2600(23)00141-8 .
doi: 10.1016/S2213-2600(23)00141-8
pubmed: 37187192
Ely EW. The ABCDEF bundle: science and philosophy of how ICU liberation serves patients and families. Crit Care Med. 2017;45:321–30.
doi: 10.1097/CCM.0000000000002175
pubmed: 28098628
pmcid: 5830123
Pun BT, Balas MC, Barnes-Daly MA, Thompson JL, Aldrich JM, Barr J, et al. Caring for critically ill patients with the ABCDEF bundle: results of the ICU liberation collaborative in over 15,000 adults. Crit Care Med. 2019;47:3–14.
doi: 10.1097/CCM.0000000000003482
pubmed: 30339549
pmcid: 6298815
Mart MF, Pun BT, Pandharipande P, Jackson JC, Ely EW. ICU survivorship—the relationship of delirium, sedation, dementia, and acquired weakness. Crit Care Med. 2021;Publish Ahead of Print: 1227–40.
Iwashyna TJ. Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med. 2010;153:204–5.
doi: 10.7326/0003-4819-153-3-201008030-00013
pubmed: 20679565
Latronico N, Minelli C, Eikermann M. Prediction of long-term outcome subtypes in ARDS: first steps towards personalised medicine in critical care. Thorax. 2017;72:1067–8.
doi: 10.1136/thoraxjnl-2017-210775
pubmed: 28988218
Sevin CM, Bloom SL, Jackson JC, Wang L, Ely EW, Stollings JL. Comprehensive care of ICU survivors: development and implementation of an ICU recovery center. J Crit Care. 2018;46:141–8.
doi: 10.1016/j.jcrc.2018.02.011
pubmed: 29929705
pmcid: 6020044
Herridge MS, Azoulay É. Outcomes after critical illness. N Engl J Med. 2023;388:913–24.
doi: 10.1056/NEJMra2104669
pubmed: 36884324
Elliott D, Davidson JE, Harvey MA, Bemis-Dougherty A, Hopkins RO, Iwashyna TJ, et al. Exploring the scope of post-intensive care syndrome therapy and care: engagement of non-critical care providers and survivors in a second stakeholders meeting. Crit Care Med. 2014;42:2518–26.
doi: 10.1097/CCM.0000000000000525
pubmed: 25083984